Scarica l'app Stockscreener
9.51
3.35%
-0.33
Dopo l'orario di chiusura:
9.45
-0.06
-0.63%
Puma Biotechnology Inc Borsa (PBYI) Ultime notizie
Puma Biotechnology Inc (NASDAQ: PBYI) Share Price, PBYI Stock News, PBYI Share Price & Updates - Kalkine
Puma Biotechnology Advances Alisertib Combo Trial in Small Cell Lung Cancer - TipRanks
PBYI's Alisertib Combo Phase II Study in Small Cell Lung Cancer Begins - Yahoo Finance
Puma Biotechnology Initiates ALISCA®-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung Cancer - biospace.com
Puma Biotechnology initiates phase II lung cancer trial By Investing.com - Investing.com Nigeria
Puma Biotechnology initiates phase II lung cancer trial - Investing.com
Puma Biotechnology Director Wilson Troy Edward Offloads 5,000 Shares at $9.10 on September 14, 2026 - Kalkine Media
PUMA BIOTECHNOLOGY (NASDAQ: PBYI) Director Cesano Alessandra Sells 62,150 Shares at $9.12 Following Option Exercise - Kalkine Media
Puma biotechnology director Cesano sells shares worth $566,994 By Investing.com - Investing.com Canada
Puma Biotechnology director Troy Wilson sells $45,500 in stock By Investing.com - Investing.com Canada
Puma biotechnology director Cesano sells shares worth $566,994 - Investing.com
Puma Biotechnology director Troy Wilson sells $45,500 in stock - Investing.com
Puma Biotechnology (NASDAQ: PBYI) director exercises 50K options, sells 62K shares - stocktitan.net
Puma Biotechnology (PBYI) Trades Essentially Flat at $9.26, Holding Above $8.80 SupportSweep Order Flow - careplusvn.com
Puma Biotechnology at H.C. Wainwright conference: sales, pipeline gains - Investing.com
Puma Biotechnology at H.C. Wainwright conference: sales, pipeline gains By Investing.com - Investing.com Canada
Insider at Puma Biotechnology (NASDAQ: PBYI) files notice to sell shares - Stock Titan
Puma Biotechnology (PBYI) director lines up $45.5K stock sale - Stock Titan
Puma Biotechnology CEO Alan Auerbach presents at H.C. Wainwright Global Investment Conference - Bitget
Puma Biotechnology to Present at H.C. Wainwright’s 28th Annual Global Investment Conference - BioSpace
Axsome (AXSM) Down 3.7% Since Last Earnings Report: Can It Rebound? - Zacks Investment Research
Puma Biotechnology: NERLYNX Funds Their Potential Next Oncology Franchise (NASDAQ:PBYI) - Seeking Alpha
Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why - Eastern Progress
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)September 3, 2026 - biospace.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4) - TradingView
InvestingPro’s fair value model spotted Puma Biotech’s 95% rally By Investing.com - Investing.com
Puma Biotechnology (PBYI) Pulls Back 1.93% to $9.14, Pressing Closer to Key SupportMcClellan Summation - vinanet.vn
PBYI | PUMA BIOTECHNOLOGY INC FinancialsRevenue Breakdown - Quiver Quantitative
Puma (PBYI) Latest Quarter: The Available Earnings Metric Delivers a Beat; Investor Response: The Stock Ends Down 4.00% for the Current SessionEarnings Call Q&A - careplusvn.com
Puma Biotechnology (PBYI) Q2 2026 Earnings Call Transcript - AOL.com
Puma (PBYI) Latest Quarter: EPS Lands Above Forecast in the Current Update; Trading Move: Shares Move 4.76% Up in the Latest SessionEPS Growth Report - vinanet.vn
Puma Biotechnology (NASDAQ:PBYI) Upgraded at Wall Street Zen - MarketBeat
Puma Biotechnology Inc (PBYI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is Puma Biotechnology (PBYI) a Great Value Stock Right Now? - Yahoo Finance
Puma Biotechnology, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PBYI) 2026-08-10 - Seeking Alpha
Puma Biotechnology Reports $56.5M Revenue and Profitability in Q2 - sekbernews.id
Puma Biotechnology (PBYI) Stock Jumps On Profit Strength As Earnings Outlook Fades - Sahm
Puma Biotechnology (NASDAQ:PBYI) Issues Earnings Results, Beats Expectations By $0.15 EPS - MarketBeat
Puma Biotech earnings beat by $0.16, revenue topped estimates - Investing.com Nigeria
TD Cowen Forecasts Strong Price Appreciation for Puma Biotechnology (NASDAQ:PBYI) Stock - marketbeat.com
Transcript : Puma Biotechnology, Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
PBYI Q2 Earnings & Sales Beat Estimates, 2026 Guidance Raised - Yahoo Finance
Puma Biotechnology, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Puma Biotechnology’s Douglas M. Hunt sells $69,904 in shares - Investing.com
Puma Biotechnology Q2 Earnings Call Highlights - MarketBeat
Puma Biotechnology Reports Second Quarter 2026 Financial Results - biospace.com
Puma Biotechnology Inc (PBYI) (Q2 2026) Earnings Call Highlights: Debt-Free Status and Raised ... - finance.yahoo.com
Puma Biotech (PBYI) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
Earnings call transcript: Puma Biotechnology tops Q2 2026 estimates as profit returns - Investing.com
Puma Biotechnology Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Puma Biotech: Q2 Earnings Snapshot - aol.com
PUMA BIOTECHNOLOGY, INC. 2026: Revenue $56.5M, EPS $0.16— 10-Q Summary - TradingView
Puma Biotechnology, Inc. Provides Earnings Guidance for the Third Quarter of 2026 - marketscreener.com
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):